EFFECTENE
LIVE

Serial Number

75555969

Owner

QIAGEN GMBH

Attorney

Victoria Friedman

Filing Date

Sep 21, 1998

Add to watchlist:

No watchlists yet
View on USPTO

EFFECTENE Trademark

Serial Number: 75555969 • Registration: 2460739

EFFECTENE is a trademark filed by QIAGEN GMBH on September 21, 1998. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (210 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Trademark Details

Filing Date

September 21, 1998

Registration Date

June 19, 2001

Published for Opposition

March 27, 2001

Goods & Services

[KITS FOR THE PREPARATION OF NUCLEIC ACIDS CONSISTING PRIMARILY OF LABORATORY APPARATUS IN THE NATURE OF FLASKS, FILTERS, COLUMNS, BOTTLES, REACTION TUBES AND RECEPTACLES, ALL CONTAINING CHEMICAL BUFFERS AND LIPIDS; SCIENTIFIC LABORATORY EQUIPMENT, NAMELY, PIPETTES, BOTTLES, COLLECTION TUBES, COLLECTION RECEPTACLES; SCIENTIFIC LABORATORY DEVICES FOR INDUSTRY AND RESEARCH USE, NAMELY, FLASKS, FILTERS, CHROMATOGRAPHIC COLUMNS, AND REACTION TUBES]

[Medical and veterinary diagnostic agents for clinical laboratory use; clinical diagnostic agents for use in laboratory assays for human and veterinary medical use]

Chemical preparations for manufacturing use in chemical, pharmaceutical and biotechnology industries and for scientific laboratory use, namely, reagents for altering the molecular structure of polymers; biological agents for laboratories for scientific and research use; kits for the preparation of nucleic acids consisting primarily of chemicals in the nature of buffers and lipids contained in flasks,m filters, columns, bottles, reaction tubes and receptacles for scientific and research laboratory use; chemical preparations for introducing molecules and molecule aggregates into prokaryotic and eukaryotic cells; namely, peptides and/or nucleic acids; kits consisting primarily of peptides and/or nucleic acids for introducing molecules and molecule aggregates into prokaryotic and eukaryotic cells; chemical preparation for scientific use, namely, transfection reagents for the isolation and purification of nucleic acids; biological agents for use in the manufacture of pharmaceuticals; diagnostic agents for scientific and/or research use in the pharmaceutical, medical and veterinary fields; scientific and/or research diagnostic agents for use in laboratory assays for human and veterinary medical and phytopathological use

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 30, 2021 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Sep 30, 2021 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 30, 2021 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 30, 2021 APRE
TEAS SECTION 8 & 9 RECEIVED
May 26, 2021 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 19, 2020 REM2
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jul 1, 2011 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jul 1, 2011 89AG
CASE FILE IN TICRS
Jun 23, 2011 CFIT
CASE FILE IN TICRS
Jun 22, 2011 CFIT
TEAS SECTION 8 & 9 RECEIVED
Jun 17, 2011 E89R
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Jul 22, 2007 8.PR
ASSIGNED TO PARALEGAL
Jul 11, 2007 PLGL
REGISTERED - SEC. 8 (6-YR) FILED
Jun 13, 2007 8.AF
TEAS SECTION 8 RECEIVED
Jun 13, 2007 ES8R
REVIEW OF CORRESPONDENCE COMPLETE
Sep 9, 2006 CORV
PAPER RECEIVED
Aug 21, 2006 MAIL
REGISTERED-PRINCIPAL REGISTER
Jun 19, 2001 R.PR
PUBLISHED FOR OPPOSITION
Mar 27, 2001 PUBO
NOTICE OF PUBLICATION
Mar 14, 2001 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 16, 2000 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2000 CRFA
FINAL REFUSAL MAILED
Jan 18, 2000 CNFR
Sec. 1(B) CLAIM DELETED
Nov 24, 1999 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 1999 CRFA
NON-FINAL ACTION MAILED
May 20, 1999 CNRT
ASSIGNED TO EXAMINER
Apr 22, 1999 DOCK